SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil is experiencing a dramatic surge driven by rising oil prices amidst escalating Middle East tensions and concerns over the Strait of Hormuz. The community is buzzing with talks of a significant short squeeze, high trading volumes, and the stock's potential for further explosive gains, leaving many shorts 'cooked'.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

SNAP is trending as investors and the community are actively discussing its recent achievement of profitability, a $1B annualized direct revenue run rate, and over 25 million Snapchat+ subscribers, signaling a potential turnaround. Many believe the stock is significantly undervalued given these operational milestones and its leadership in AI/AR technology, fueling speculation of a potential acquisition.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending after reporting record Q4 and full-year 2025 revenue with significant profitability improvements, sparking community debate over its perceived undervaluation and multi-billion-dollar AI infrastructure pipeline against persistent skepticism regarding management's past execution and the stock's price action.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

Escalating geopolitical tensions in the Middle East, driven by reported attacks on US interests and threats to the Strait of Hormuz, are sparking community debate on whether the market's current resilience is a manipulated 'patriotic bump' or a genuine buying opportunity amidst surging oil prices and anticipated volatility for the broader SPY.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum is surging amid community excitement over a multi-billion dollar strategic investment by a leading AI chipmaker to advance optical infrastructure, reinforcing its perceived critical role in next-gen data centers, though its high valuation is actively debated among investors.

Palladyne AI Corp. engages in the design, development, and manufacture of industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Its products include Palldyne IQ and Palladyne Pilot. The company was founded by Fraser M. Smith and Benjamin G. Wolff in 2015 and is headquartered in Salt Lake City, UT.

Palladyne AI Corp.

Palladyne AI Corp. is trending due to recently secured multi-domain defense contracts, including an Air Force project leveraging its SwarmOS AI platform for autonomous system coordination and another for a missile propulsion subsystem. This news is fueling intense community discussion about its undervalued position, significant short interest with rising borrow costs, and long-term growth potential in the evolving AI and drone warfare sectors.

BlackRock Institutional Trust Company N.A. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF (EWY) is trending as its major holdings, Samsung and SK Hynix, surge amidst the AI-driven memory supercycle and recent DRAM/NAND price hikes. While some debate if its parabolic gains represent a market bubble, others view current dips as tactical buying opportunities, citing robust fundamentals and attractive valuations compared to US benchmarks.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd is trending amid escalating Middle East tensions and threats to oil shipping in the Strait of Hormuz, which are driving crude prices higher across the sector. The community is actively discussing INDO's potential to catch up to other booming energy stocks, alongside anticipation of news regarding its drilling operations.

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

Larimar Therapeutics is experiencing significant discussion after receiving FDA Breakthrough Therapy Designation for its Friedreich's Ataxia treatment, nomlabofusp, sparking bullish sentiment and comparisons to multi-billion dollar acquisitions, while a recently priced public offering at $5.00 per share drives ongoing debate regarding immediate dilution versus funding a promising pipeline.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending with divided community sentiment as bullish investors highlight its strengthened position following OpenAI's Pentagon contract win, viewing recent market dips as a buying opportunity, while others express frustration over its volatile price action and perceived inability to hold gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Artisan Partners Limited Partnership Boosts Stock Position in Tarsus Pharmaceuticals, Inc. $TARS

Artisan Partners Limited Partnership lifted its stake in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) by 3.5% in the third quarter, according to the company in its most recent...

Tarsus Pharmaceuticals (NASDAQ:TARS) Downgraded to Hold Rating by Wall Street Zen

Wall Street Zen lowered Tarsus Pharmaceuticals from a "buy" rating to a "hold" rating in a research note on Saturday...

Tarsus Pharmaceuticals (NASDAQ:TARS) Downgraded to Hold Rating by Zacks Research

Zacks Research cut shares of Tarsus Pharmaceuticals from a "strong-buy" rating to a "hold" rating in a report on Wednesday...

HC Wainwright Brokers Decrease Earnings Estimates for TARS

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) - Equities research analysts at HC Wainwright dropped their Q1 2026 earnings per share (EPS) estimates for shares of Tarsus Pharmaceuticals in...

Tarsus Pharmaceuticals (NASDAQ:TARS) Given New $105.00 Price Target at Oppenheimer

Oppenheimer lifted their price target on shares of Tarsus Pharmaceuticals from $95.00 to $105.00 and gave the company an "outperform" rating in a report on Wednesday...

Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target Raised to $90.00 at Guggenheim

Guggenheim upped their target price on Tarsus Pharmaceuticals from $87.00 to $90.00 and gave the company a "buy" rating in a report on Wednesday...

Analysts Offer Predictions for TARS FY2030 Earnings

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) - Analysts at HC Wainwright issued their FY2030 EPS estimates for Tarsus Pharmaceuticals in a research report issued on Tuesday, February...

Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap Up - Time to Buy?

Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap Up - Here's What Happened...

Tarsus Pharmaceuticals Q4 Earnings Call Highlights

Tarsus Pharmaceuticals (NASDAQ:TARS) reported fourth-quarter and full-year 2025 results highlighting rapid growth for XDEMVY, the company's FDA-approved treatment for Demodex blepharitis (DB), and...

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Beats Revenue Estimates

Tarsus Pharmaceuticals (TARS) delivered earnings and revenue surprises of -5.26% and +4.63%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. It is also developing TP-04 for the potential treatment of Ocular Rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease. The company was founded by Bobak Azamian and D. Michael Ackermann in 2017 and is headquartered in Irvine, CA.

Tarsus Pharmaceuticals Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $MDB earnings today?

Current Price	$77.43
Prev Close	$75.52
Open	$73.61
Dividend Yield	0.00%
50-Day Moving Average	$72.34
Beta	0.72
Avg. Volume	541,035.80
PE Ratio	-46.92

52-Week High	$85.25
52-Week Low	$38.51
Market Capitalization	$3.21B
EPS (Annual)	-$1.59
Price to Book	9.36
Revenue Per Employee	$1.22M

TARS
Tarsus Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TARS News

TARSTarsus Pharmaceuticals Inc